IDiyas

For the Inventor, By the Inventor

Framingham, MA, United States of America

Michael E Hudson

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 104(Granted Patents)


Location History:

  • Hayden, AL (US) (2013)
  • Boston, MA (US) (2021)
  • Framingham, MA (US) (2015 - 2023)

Company Filing History:

goldMedal13 out of 43 
 
Gen9, Inc.
 patents
silverMedal1 out of 43 
 
Evonik Corporation
 patents

Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 12241057 - Methods for nucleic acid assembly and high throughput sequencing (2025-03-04),
2. 11845054 - Methods and devices for nucleic acids synthesis (2023-12-19),
3. 11130948 - Compositions and methods for multiplex nucleic acids synthesis (2021-09-28),
4. 11084014 - Methods and devices for nucleic acids synthesis (2021-08-10),
5. 11072789 - Methods for nucleic acid assembly and high throughput sequencing (2021-07-27),
6. 10982208 - Protein arrays and methods of using and making the same (2021-04-20),
7. 10927369 - Methods for sorting nucleic acids and multiplexed preparative in vitro cloning (2021-02-23),
8. 10457935 - Protein arrays and methods of using and making the same (2019-10-29),
9. 10308931 - Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis (2019-06-04),
10. 10273471 - Compositions and methods for multiplex nucleic acids synthesis (2019-04-30),
11. 10081807 - Methods for sorting nucleic acids and multiplexed preparative in vitro cloning (2018-09-25),
12. 10053719 - Compositions and methods for synthesis of high fidelity oligonucleotides (2018-08-21),
13. 9150853 - Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis (2015-10-06),
14. 8486435 - Core-sheath implant device having an inner core lobe (2013-07-16),

Title: Michael E Hudson: Innovator in Nucleic Acid Technologies

Introduction

Michael E Hudson is a prominent inventor based in Framingham, MA, known for his significant contributions to the field of nucleic acid technologies. With a total of 14 patents to his name, Hudson has made remarkable advancements in methods for nucleic acid assembly and high throughput sequencing. His work has paved the way for innovative solutions in genetic research and biotechnology.

Latest Patents

Hudson's latest patents include groundbreaking methods for nucleic acid assembly and high throughput sequencing. These inventions focus on the synthesis of high fidelity polynucleotides. Specifically, they relate to the concurrent enzymatic removal of amplification sequences and the ligation of processed oligonucleotides into nucleic acid assemblies. One of the key aspects of his invention is a method for producing a target nucleic acid with a predefined sequence. This method involves providing a plurality of oligonucleotides, each containing an internal sequence identical to different portions of a target nucleic acid sequence, along with flanking sequences that include primer recognition sites and restriction enzyme recognition sites. Additionally, Hudson has developed methods and devices for synthesizing polynucleotides with predefined sequences on a support, utilizing primer extension and assembly techniques.

Career Highlights

Throughout his career, Michael E Hudson has worked with notable companies such as Gen9, Inc. and Evonik Corporation. His experience in these organizations has contributed to his expertise in nucleic acid technologies and has facilitated the development of his innovative patents.

Collaborations

Hudson has collaborated with esteemed colleagues in the field, including Joseph M Jacobson and Daniel Schindler. These partnerships have further enhanced his research and development efforts in nucleic acid synthesis and assembly.

Conclusion

Michael E Hudson stands out as a leading inventor in the realm of nucleic acid technologies, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing genetic research. His contributions continue to influence the biotechnology landscape significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…